SCHEMBL9924243

SCHEMBL9924243

O=C(/N=C(/NCc1ccc(F)cc1F)N[C@H]1CC[C@H](O)CC1)c1ccc(F)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.39
SIGMAR1 Q99720 2/20 0.38
MCHR1 Q99705 3/20 0.36
KLKB1 P03952 2/20 0.36
MAPK14 Q16539 1/20 0.35
EPHX2 P34913 2/20 0.35
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
MAOB P27338 1/20 0.35
KCNQ3 O43525 1/20 0.34
KCNQ2 O43526 1/20 0.34
PPARG P37231 1/20 0.34
NR1H4 Q96RI1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924237 0.93 SIGMAR1 (0.39) SIGMAR1MCHR1MAPK14ALDH1A1TSHR
SCHEMBL9924271 0.91 P2RX7 (0.43) P2RX7
SCHEMBL9924272 0.91 P2RX7 (0.41) P2RX7MCHR1ALDH1A1MEN1NPC1
SCHEMBL17206627 0.89 KMT2A (0.42) SIGMAR1MCHR1ALDH1A1TSHRMEN1
SCHEMBL9924242 0.88 LMNA (0.40) MCHR1ALDH1A1RAB9A
SCHEMBL9923858 0.87 ALDH1A1 (0.41) P2RX7SIGMAR1MCHR1KLKB1MAPK14
SCHEMBL9924239 0.86 MAPK14 (0.36) P2RX7MCHR1MAPK14
SCHEMBL9924241 0.85 SSTR3 (0.40) P2RX7SIGMAR1MCHR1MAPK14ALDH1A1
SCHEMBL9924238 0.85 P2RX7 (0.40) P2RX7SIGMAR1MCHR1MAPK14ALDH1A1
SCHEMBL9924429 0.85 NTRK1 (0.43) SIGMAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed